The application of Chinese medicine to novel drug discovery

被引:100
作者
Sucher, Nikolaus J. [1 ]
机构
[1] Roxbury Community Coll, Roxbury Crossing, MA 02120 USA
关键词
Chinese materia medica; Chinese medicine; drug discovery; ethnobotany; ethnomedicine; ethnopharmacology; RANDOMIZED CONTROLLED-TRIALS; NATURAL-PRODUCTS; TRADITIONAL MEDICINE; BIOACTIVE COMPOUNDS; QUALITY-CONTROL; STRATEGY; TARGET; IDENTIFICATION; BIOSYNTHESIS; CONSTITUENTS;
D O I
10.1517/17460441.2013.739602
中图分类号
R9 [药学];
学科分类号
100702 [药剂学];
摘要
Introduction: The apparent productivity crisis in the pharmaceutical industry and the economic and political rise of China have contributed to renewed interest in the application of Chinese medicine for drug discovery. Areas covered: The author presents an overview of the historical development and basic principles of theory and practice of Chinese herbal medicine, its materia medica and prescription formulas, and discusses the motivation for and rationale of its application to drug discovery. Furthermore, the author distinguishes the five main approaches to drug discovery from Chinese herbal medicine, based on the decreasing amount and detail of historical and clinical Chinese medicine knowledge that informed the research effort. Expert opinion: Many compounds that have been isolated from the Chinese materia medica exhibit pharmacological activities comparable to pharmaceutical drugs. With the exception of the antimalarial drug artemisinin, however, this knowledge has not led to the successful development of new drugs outside of China. The chance of success in a Chinese medicine-based drug discovery effort will be increased by consideration of the empirical knowledge that has been documented over many centuries in the historical materia medica and prescription literature. Most Chinese medicine-derived compounds affect more than one target and do not correspond to the one compound/onetarget drug discovery paradigm. A new frontier is opening up with the development of drugs consisting of combinations of multiple compounds acting on multiple targets under the paradigm of network pharmacology. The ancient practice of combining multiple drugs in prescription formulas can serve as inspirational analogy and a practical guide.
引用
收藏
页码:21 / 34
页数:14
相关论文
共 104 条
[1]
[Anonymous], 1991, ENGLISH CHINESE ENCY
[2]
In-silico studies in Chinese herbal medicines' research: Evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date [J].
Barlow, D. J. ;
Buriani, A. ;
Ehrman, T. ;
Bosisio, E. ;
Eberini, I. ;
Hylands, P. J. .
JOURNAL OF ETHNOPHARMACOLOGY, 2012, 140 (03) :526-534
[3]
Borris RP, 1996, J ETHNOPHARMACOL, V51, P29, DOI 10.1016/0378-8741(95)01347-4
[4]
What Is the Best Strategy for Preclinical Testing of Botanicals? A Critical Perspective [J].
Butterweck, Veronika ;
Nahrstedt, Adolf .
PLANTA MEDICA, 2012, 78 (08) :747-754
[5]
Drug-like Properties: Guiding Principles for the Design of Natural Product Libraries [J].
Camp, David ;
Davis, Rohan A. ;
Campitelli, Marc ;
Ebdon, James ;
Quinn, Ronald J. .
JOURNAL OF NATURAL PRODUCTS, 2012, 75 (01) :72-81
[6]
PROGRESS IN TRADITIONAL CHINESE MEDICINE [J].
CHAN, K .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (06) :182-187
[7]
CHINESE HERBAL MEDICINES REVISITED - A HONG-KONG PERSPECTIVE [J].
CHAN, TYK ;
CHAN, JCN ;
TOMLINSON, B ;
CRITCHLEY, JAJH .
LANCET, 1993, 342 (8886-7) :1532-1534
[9]
Use frequency of traditional Chinese medicine in Taiwan [J].
Chen, Fang-Pey ;
Chen, Tzeng-Ji ;
Kung, Yen-Ying ;
Chen, Yu-Chun ;
Chou, Li-Fang ;
Chen, Fan-Jou ;
Hwang, Shinn-Jang .
BMC HEALTH SERVICES RESEARCH, 2007, 7 (1)
[10]
Chen KK, 1930, EPHEDRINE AND RELATE